Loading market dashboard
NervGen Pharma Corp.
NGEN.VHealthcareTSXVCA
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
NervGen Pharma Corp. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $677.83M | $677.83M - $677.83M | $0.00 | $4.768 | 1 |
| Dec 2028 | $213.05M | $213.05M - $213.05M | $0.00 | $1.164 | 2 |
| Dec 2027 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.43 | 0 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.391 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.299 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.315 | 0 |